Evidence map›Paper›PMID 31830326›Full record

ArticleGenetic epidemiology2020

An adaptive test for meta-analysis of rare variant association studies.

Tianzhong Yang, Junghi Kim, Chong Wu, Yiding Ma, Peng Wei, Wei Pan

Abstract read
In one paragraph

Article in Genetic epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tianzhong YangDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-0162-7740
Junghi KimDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Chong WuDepartment of Statistics, Florida State University, Tallahassee, Florida.ORCID 0000-0002-8400-1785
Yiding MaDepartment of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas.
Peng WeiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wei PanDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-1159-0582

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Association analysis of rare variants with sequencing dataR01HL116720 · NHLBI · UNIVERSITY OF MINNESOTA · PI PAN, WEI, WEI, PENG · 2013 to 2020
$3.3M
Powerful Inference and Prediction for Genetic AssociationR01HL105397 · NHLBI · UNIVERSITY OF MINNESOTA · PI PAN, WEI, SHEN, XIAOTONG TOM · 2011 to 2018
$2.9M
Estimation and Inference of Gene Regulatory NetworksR01GM126002 · NIGMS · UNIVERSITY OF MINNESOTA · PI PAN, WEI, SHEN, XIAOTONG TOM · 2017 to 2020
$1.4M
Statistical Methods for Genomic DataR01GM113250 · NIGMS · UNIVERSITY OF MINNESOTA · PI PAN, WEI · 2014 to 2017
$702k
Integrating genomic and imaging endophenotypes in GWASR21AG057038 · NIA · UNIVERSITY OF MINNESOTA · PI PAN, WEI · 2017 to 2018
$405k
Medical Research Council G9815508Medical Research Council MC_PC_15018Medical Research Council MC_PC_19009NCI NIH HHS P30 CA016672NHLBI NIH HHS R01 HL105397NHLBI NIH HHS R01 HL116720NIA NIH HHS R21 AG057038NIGMS NIH HHS R01 GM113250NIGMS NIH HHS R01 GM126002
6 · The paper itself

Abstract

Single genome-wide studies may be underpowered to detect trait-associated rare variants with moderate or weak effect sizes. As a viable alternative, meta-analysis is widely used to increase power by combining different studies. The power of meta-analysis critically depends on the underlying association patterns and heterogeneity levels, which are unknown and vary from locus to locus. However, existing methods mainly focus on one or only a few combinations of the association pattern and heterogeneity level, thus may lose power in many situations. To address this issue, we propose a general and unified framework by combining a class of tests including and beyond some existing ones, leading to high power across a wide range of scenarios. We demonstrate that the proposed test is more powerful than some existing methods in simulation studies, then show their performance with the NHLBI Exome-Sequencing Project (ESP) data. One gene (B4GALNT2) was found by our proposed test, but not by others, to be statistically significantly associated with plasma triglyceride. The signal was driven by African-ancestry subjects but it was previously reported to be associated with coronary artery disease among European-ancestry subjects. We implemented our method in an R package aSPUmeta, publicly available at https://github.com/ytzhong/metaRV and will be on CRAN soon.

Indexed as

Meta-Analysis as TopicModels, GeneticBlack PeopleCoronary Artery DiseaseExomeGenome-Wide Association StudyHumansN-AcetylgalactosaminyltransferasesPhenotypeTriglyceridesWhite Peoplebeta-1,4-N-acetyl-galactosaminyl transferase 2N-AcetylgalactosaminyltransferasesTriglyceridesaSPUgenetic heterogeneitystatistical powerwhole-exome sequencingwhole-genome sequencing

Identifiers

PMID31830326
PMCPMC6980317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.